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Introduction
Human history is filled with great examples where light
has played an important role in medicine. This idea has been
considered more seriously in recent years, originating a new field
that combines health science, physics and engineering. This
connection is presently defined as biophotonics. The recent
burst of activity experienced by this field is a result of a series of
developments achieved in the last few years. The first important
milestone in the development of biophotonics was transformation
of light sources, like lasers and LEDs, in accessible tools for
research and applications. Lasers, in special, are now broadly used
as excitation light sources for disease diagnostics and as optical
scalpels in interventional surgery. Another important aspect of the
recent valuable progress is the advance of photochemistry applied
to molecules of biological interest. Today, biophotonics can bring
new technologies to define a bright future to biomedical research
and clinical applications. This important advance comes in a good
time, since the present growing and seniority of our modern
society is demanding the development of new possibilities,
that within the economical reality, make treatment, diagnostics and
prevention techniques available to everyone. Biophotonics is
certainly a source of solutions in this aspect.
Purpose
The purpose of this contribution is to highlight recent
development that indicates modern applications for the treatment
and diagnostics of hepatic diseases. In special, we would like to
focus the attention to the tools and principles that compose the
optical diagnostics of hepatic related disease. Application to
evaluate liver steatosis and liver graft viability for transplantation
are given indications of optical diagnostics becoming a great
reality for clinical use.
In a recent article published by our group1 the use and the
potentiality for optical biopsy to evaluate the degree of steatosis in
a liver animal model was demonstrated. Almost simultaneously,
another article demonstrated the possibility to evaluate liver drafts
has also impacted the community. That result has called the
attention of many international groups, and the article ends
generating a special editorial about the subject on the same
journal. This is certainly a nice starting point to introduce the
possibilities of such techniques for clinical applications.
Techniques
In brief, spectroscopic signals can indicate biochemical
changes, and these generally precede the morphological changes
observed in histology. Most important, however, is the fact that
the information provided by spectroscopy is quantitative, and
thus it can bring an added degree of objectivity to the process of
diagnosing disease.
Several spectroscopic techniques can be used to
diagnose tissue: reflectance, fluorescence, infrared absorption,
Raman spectroscopy among others2-4. Each of these has its own
special features and potential applications. Laser-induced
Fluorescence (LIF) has been shown to be a very sensitive
analytical technique for biochemical analysis at ultratrace levels.
This technique has also been demonstrated to be a useful tool for
monitoring DNA damage and for cancer diagnostics.
In the article presented in reference1, the fluorescence
spectroscopy system is described. Basically the system is composed
of: i) One spectrometer, which goes from 350 nm up to 850 nm; ii)
One Y-shaped fiber, which delivers the laser light through one
central fiber and collects the fluorescence from the tissue using six
periferical fibers; iii) And an excitation source, emitting at 532 nm
(doubled-frequency Nd:YAG). The laser power is in the order of 5
mW, assuring no thermal effect on the incident spot.  It should be
pointed out that the signal from the backscattering (emission at the
same wavelength of excitation light) is about thousand times more
intense than the one from the broad fluorescence band. To simplify
the analyses we used an optical filter to reduce it one thousand
times; this way both parts of the spectrum present comparable
intensities. The spectrum was collected by direct contact
between the fiber and the liver. To protect the fiber and to avoid
contamination from one measurement to the other, we used a
1 Institute of Physics Institute of São Carlos of University of São Paulo, Brazil.
2 Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
New perspectives for optical techniques in diagnostic and treatment of hepatic diseases
Acta Cirúrgica Brasileira - Vol. 25 (2) 2010  -  215
non-fluorescent transparent plastic film between the liver tissue
and the fiber. Once the fluorescence spectrum is obtained, a
mathematical procedure is performed, allowing the verification of
modifications in the spectrum, depending on tissue characteristics
as steatosis degree or other tissue modifications.
Samples
The investigated animals were divided into groups
according to the induced steatosis, which were determined through
histological exam.  Fat concentration in the liver was evaluated using
lipid extraction techniques well demonstrated in the literature.
The excitation frequency is represented by the sharp
observed peak. Thereafter, the broad band extended from the
excitation to longer wavelengths is fully associated with the
fluorescence emitted by the tissue. Because the quantity of fat
interacts differently with the light as compared with the healthy
tissue, the fluorescence, peak decrease the overall amplitude.
Interesting fact is that this decrease in fluorescence amplitude
and a determined Steatosis Fluorescence Factor (SFF) is directly
correlated with the quantity of fat in the tissue.
The existence of a good correlation allows the determination
of a mathematical relation to determine the degree of steatosis once
the amplitude of fluorescence is determined. Once the process is
fully understood, the necessity of obtain the full spectrum is
no longer necessary. Just the reading of a single fluorescence
wavelength allows this determination.  During excitation, there is
a collection of molecules that contributes to the broad emission.
Coenzymes such as flavins, proteins and acid arachidonic,
presented in the liver may be the main contributors for the
observed fluorescence. In special, riboflavin seems to be connected
with the mitochondrial activity, which may well be the responsible
for the fluorescence decrease as the quantity of fat increases.
Another important component is the lipofuscin, which presence in
the autofluorescence of health tissue is dominant, with remarkable
modification during the occurrence of steatosis. This biochemistry
and many others, result in decreasing the overall fluorescence as
the degree of steatosis becomes severe.
This demonstration of “proof of principles” using an
animal model, certainly open up a great deal of possibilities for
clinical use of the technique as well as on the experimental part.
Starting by the experimental part, because the sampling is local
and can even be done in the interior of the organ by fiber insertion,
one will be able to understand spatial distribution and development
of steatosis. That will provide enough insights for a deep
understanding of this process. The understating of animal models
will certainly contribute for the present clinical initiatives for
patients with high degree of steatosis. On the clinical site, there
seems to be many advantages for the use of fluorescence when
compared to conventional biopsy. The fact that this analysis can
be performed in real time, open many opportunities for clinical
decision during the surgical procedure, as well as during the organ
collection for transplantation, avoiding long waiting for biopsy
result. Since steatosis is an important factor related to the success
of liver transplantion, the inclusion of fluorescence detection
during the graft evaluation, part of the liver transplantation
procedure, will constitute a good auxiliary tool.
Besides the evaluation of steatosis, a recent published
work, demonstrated experimentally, the applicability of LIF in
evaluating the viability of rat liver previously perfused with saline
solution5. Mitochondrial function and cellular ATP content of
the liver were used as indicators of its metabolic status.  The
spectroscopic findings were then compared on a time scale with
the mitochondrial function. Therefore, the aim of the study was to
verify LIF’s capability to detect changes taking place in the organ.
Structural changes usually occur at later stages and frequently
denote irreversible damage.
The satisfactory results obtained in the animal studies of
liver steatosis1 and liver monitoring after perfusion5 motivated the
clinical study where the potentiality of the fluorescence spectroscopy
for liver graft evaluation has been investigated in transplantation
patients. The preliminary results were recently published6.
Each spectrum has a common peak centered at the
excitation wavelength followed by a broad emission band at
longer wavelengths. This broad band of fluorescence has various
contributions. We believe that many endogenous chromophores
contribute to this band. The fluorescence of reduced nicotinamide
adenine dinucleotide (NADH) may have special contribution as it
is an essential part of the cellular energy metabolism, and it could
therefore reveal the energy status of the cell. Although isolated
NADH does not show prominent fluorescence under green (532nm)
excitation, in the intact organ (hepatocellular medium), NADH
fluorescence may behave in a significantly altered manner, to the
point of responding to green excitation.  This, however, remains to
be investigated.   In order to obtain better organ preservation and
consequently increase the donor pool, there is a lot still to be learned
about the metabolism after organ perfusion and removal as well as
about how individual chromophores in a cellular environment
contribute to the fluorescence spectrum. The results show that
fluorescence spectroscopy is potentially a powerful tool to be
employed in evaluating the level of tissue integrity. This could
be of great value in liver transplantation by providing means for
evaluating the organ to be implanted.  Not only could this
technique offer information on the organ viability, through a non-
invasive procedure and with real-time response, it can also give a
quantitative result. This is of relevance as it would remove the
subjectivity in the surgeon evaluation without increasing the time
needed for analysis. The results also indicated that fluorescence
may detect the appearance of new substances resulting from the
decomposition and/or modification of the cellular structures, which
could be important in analyzing the integrity of the tissue structure
and function. Much remains to be done in order to turn these
promises into reality in the surgical room.
The ideal imagined situation where nondestructive
optical techniques can be used in biomedical diagnostics seems to
be increasingly becoming reality. The analytical capabilities of the
fluorescence technique introduced by laser coupled to fibers, make
this tool very attractive for use together with laparoscopy or in
interstitial organ analysis. Special experiments for inside organ
analyses by the introduction of fibers are presently ongoing in
our laboratories. That will create a procedure that goes beyond
conventional biopsy. In special, for liver, is coming the time that
not only light will be used to diagnostics, but also to treat diseases.
Photodynamic therapy for hepatocarcinoma is becoming also a
reality.
Scientists related to medical areas shall consider the
possibility to experience within this field which is promising and
full of new possible applications.
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